3igg: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3igg.png|left|200px]] | [[Image:3igg.png|left|200px]] | ||
{{STRUCTURE_3igg| PDB=3igg | SCENE= }} | {{STRUCTURE_3igg| PDB=3igg | SCENE= }} | ||
===Novel CDK-5 inhibitors - crystal structure of inhibitor EFQ with CDK-2=== | ===Novel CDK-5 inhibitors - crystal structure of inhibitor EFQ with CDK-2=== | ||
{{ABSTRACT_PUBMED_19700321}} | {{ABSTRACT_PUBMED_19700321}} | ||
==About this Structure== | ==About this Structure== | ||
[[3igg]] is a 1 chain structure of [[Cell Division Protein Kinase 2]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3IGG OCA]. | |||
==See Also== | |||
*[[Cell Division Protein Kinase 2|Cell Division Protein Kinase 2]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:019700321</ref><references group="xtra"/> | ||
[[Category: Cyclin-dependent kinase]] | [[Category: Cyclin-dependent kinase]] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
| Line 35: | Line 26: | ||
[[Category: Nucleotide-binding]] | [[Category: Nucleotide-binding]] | ||
[[Category: Phosphoprotein]] | [[Category: Phosphoprotein]] | ||
[[Category: Protein kinase]] | [[Category: Protein kinase]] | ||
[[Category: Serine/threonine protein kinase]] | [[Category: Serine/threonine protein kinase]] | ||
[[Category: Serine/threonine-protein kinase]] | [[Category: Serine/threonine-protein kinase]] | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||
Revision as of 10:57, 27 July 2012
Novel CDK-5 inhibitors - crystal structure of inhibitor EFQ with CDK-2
Template:ABSTRACT PUBMED 19700321
About this Structure
3igg is a 1 chain structure of Cell Division Protein Kinase 2 with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Helal CJ, Kang Z, Lucas JC, Gant T, Ahlijanian MK, Schachter JB, Richter KE, Cook JM, Menniti FS, Kelly K, Mente S, Pandit J, Hosea N. Potent and cellularly active 4-aminoimidazole inhibitors of cyclin-dependent kinase 5/p25 for the treatment of Alzheimer's disease. Bioorg Med Chem Lett. 2009 Oct 1;19(19):5703-7. Epub 2009 Aug 8. PMID:19700321 doi:10.1016/j.bmcl.2009.08.019